Effectiveness of riamilovir in preventing respiratory viral infection among young people from organized collectives

Effectiveness of riamilovir in preventing respiratory viral infection among young people from organized collectives

Aim. To evaluate the efficacy of the antiviral drug riamilovir (trade name – «Triazavirin®») for the prevention of SARS-CoV-2 infection (COVID-19) and other acute respiratory viral infections in young people from organized groups. Materials and methods. The study involved 386 individuals aged 18–...

Full description

Saved in:
Bibliographic Details
Main Authors: Konstantin V. Kozlov, Oleg V. Maltsev, Kristina V. Kasyanenko, Vitalii S. Sukachev, Andrei V. Saulevich, Sergey S. Karyakin, Alexey D. Dubrovin, Roman N. Smirnov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2024-12-01
Series:Терапевтический архив
Subjects:
acute respiratory viral infections
acute respiratory diseases
riamilovir
nucleoside analogues
prevention
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/637437/pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items